{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:55:18Z","timestamp":1787849718989,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"European Community's Seventh Framework Program","award":["212043"],"award-info":[{"award-number":["212043"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jconrel.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T09:07:25Z","timestamp":1494493645000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease"],"prefix":"10.1016","volume":"258","author":[{"given":"Simona","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Micotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Masserini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-567X","authenticated-orcid":false,"given":"Francesca","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.05.013_bb0005","unstructured":"Alzheimer's Association national site \u2013 information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care and support resources. http:\/\/www.alz.org."},{"issue":"6101","key":"10.1016\/j.jconrel.2017.05.013_bb0010","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1228541","article-title":"Preventing Alzheimer's disease","volume":"337","author":"Selkoe","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jconrel.2017.05.013_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"77","key":"10.1016\/j.jconrel.2017.05.013_bb0020","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2017.05.013_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrneurol.2012.241","article-title":"Preclinical Alzheimer disease: the challenges ahead","volume":"9","author":"Sperling","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2017.05.013_bb0030","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.nano.2012.05.007","article-title":"Nanotechnology for neurodegenerative disorders","volume":"8","author":"Re","year":"2012","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.jconrel.2017.05.013_bb0035","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an Apo E-derived peptide affect A\u03b2 aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"issue":"42","key":"10.1016\/j.jconrel.2017.05.013_bb0040","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional liposomes reduce brain \u03b2-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models","volume":"34","author":"Balducci","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbiotec.2011.06.037","article-title":"Functionalization with Apo E-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide","volume":"156","author":"Re","year":"2010","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.05.013_bb0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","article-title":"Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice","volume":"120","author":"Lazarov","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0060","doi-asserted-by":"crossref","first-page":"e16832","DOI":"10.1371\/journal.pone.0016832","article-title":"Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APP(Sw,Ind) transgenic mice","volume":"6","author":"Valero","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.05.013_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0070","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"4","key":"10.1016\/j.jconrel.2017.05.013_bb0075","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.neuroimage.2010.10.067","article-title":"Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible tau transgenic mice (rTg4510)","volume":"54","author":"Yang","year":"2010","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.05.013_bb0095","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archneur.65.7.906","article-title":"Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study","volume":"65","author":"Steinerman","year":"2008","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.jconrel.2017.05.013_bb0100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm0797-756","article-title":"Hyperaccumulation of FAD-linked presenilin 1 variants in vivo","volume":"3","author":"Lee","year":"1997","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12017-010-8141-7","article-title":"APP transgenic mice: their use and limitations","volume":"13","author":"Balducci","year":"2011","journal-title":"NeuroMolecular Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2017.05.013_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1471-4159.2011.07510.x","article-title":"Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?","volume":"120","author":"Nalivaeva","year":"2012","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.jconrel.2017.05.013_bb0115","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer's disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0125","doi-asserted-by":"crossref","first-page":"826503","DOI":"10.1155\/2014\/826503","article-title":"Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease","volume":"2014","author":"Tian","year":"2014","journal-title":"Dis. Markers"},{"issue":"34","key":"10.1016\/j.jconrel.2017.05.013_bb0130","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1523\/JNEUROSCI.2637-09.2009","article-title":"Characterizing the appearance and growth of amyloid plaques in APP\/PS1 mice","volume":"29","author":"Yan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2017.05.013_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0460.1000201","article-title":"Application of APP\/PS1 transgenic mouse model for Alzheimer disease","volume":"5","author":"Li","year":"2015","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"issue":"1","key":"10.1016\/j.jconrel.2017.05.013_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","article-title":"Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid","volume":"23","author":"Matsuoka","year":"2003","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jconrel.2017.05.013_bb0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2014.09.015","article-title":"Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-\u03b2 levels in APP\/PS1 transgenic mice","volume":"11","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2015","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2017.05.013_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nano.2015.09.003","article-title":"The hunt for brain A\u03b2 oligomers by peripherally circulating multi-functional nanoparticles: potential therapeutic approach for Alzheimer disease","volume":"12","author":"Mancini","year":"2016","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2017.05.013_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5594","key":"10.1016\/j.jconrel.2017.05.013_bb0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.05.013_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jbiotec.2010.08.252","article-title":"The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of Alzheimer's disease","volume":"150","author":"Andersen","year":"2010","journal-title":"J. Biotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917305886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:41:55Z","timestamp":1770399715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917305886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"alternative-id":["S0168365917305886"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}